Celldex Therapeutics, Inc.CLDXNASDAQ
Loading
Cash & Equivalents Over TimeStable
Percentile Rank43
3Y CAGR-0.6%
5Y CAGR-8.0%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-0.6%/yr
vs +4.9%/yr prior
5Y CAGR
-8.0%/yr
Recent acceleration
Acceleration
-5.5pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $28.87M | +1.8% |
| 2024 | $28.36M | -18.6% |
| 2023 | $34.81M | +18.3% |
| 2022 | $29.43M | -24.8% |
| 2021 | $39.14M | -10.7% |
| 2020 | $43.84M | +290.3% |
| 2019 | $11.23M | -53.8% |
| 2018 | $24.31M | -39.7% |
| 2017 | $40.29M | -5.1% |
| 2016 | $42.46M | - |